Equities researchers at StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a research report issued on Thursday. The firm set a “hold” rating on the stock.
China Pharma Stock Performance
Shares of CPHI stock opened at $0.22 on Thursday. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.84 and a quick ratio of 0.24. China Pharma has a 1 year low of $0.17 and a 1 year high of $1.21. The firm has a fifty day moving average price of $0.21 and a 200-day moving average price of $0.28.
China Pharma (NYSE:CPHI – Get Free Report) last released its quarterly earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share (EPS) for the quarter. The company had revenue of $0.93 million for the quarter. China Pharma had a negative net margin of 70.47% and a negative return on equity of 60.19%.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Stories
- Five stocks we like better than China Pharma
- How to Evaluate a Stock Before BuyingÂ
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- 3 Warren Buffett Stocks to Buy Now
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- 3 REITs to Buy and Hold for the Long Term
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
